STOCK TITAN

[Form 4] Lightbridge Corp. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Daniel B. Magraw, a director of Lightbridge Corporation (LTBR), reported multiple equity grants dated 08/28/2025. The filing shows five separate non-derivative stock grants totaling 20,000 shares acquired on that date, increasing his beneficial ownership to 34,055 shares. The filing explains the 5,000-share grant is a restricted stock award (RSA) that vests in three equal annual installments based on continued service. The other grants are performance-based restricted stock awards (PSAs) that vest upon meeting a specified performance condition and may be forfeited if unvested by 12/31/2028. Magraw also holds employee stock options exercisable for a total of 10,821 shares at various strike prices ($3.82, $10.80, $12.60, $55.20) and expiration dates through 12/02/2029. The form is signed by an attorney-in-fact on 08/29/2025.

Daniel B. Magraw, direttore di Lightbridge Corporation (LTBR), ha segnalato più attribuzioni di azioni datate 08/28/2025. La comunicazione indica cinque distinti assegni non derivativi per un totale di 20.000 azioni acquisiste in quella data, portando la sua titolarità effettiva a 34.055 azioni. Il documento specifica che la concessione di 5.000 azioni è un premio in azioni vincolate (RSA) che matura in tre rate annuali uguali in base al servizio continuativo. Le altre assegnazioni sono premi in azioni vincolate legati a performance (PSA) che maturano al conseguimento di una condizione di performance stabilita e possono essere perse se non maturate entro il 12/31/2028. Magraw detiene inoltre opzioni azionarie da dipendente esercitabili per un totale di 10.821 azioni a diversi prezzi di esercizio ($3.82, $10.80, $12.60, $55.20) e con scadenze fino al 12/02/2029. Il modulo è firmato da un procuratore il 08/29/2025.

Daniel B. Magraw, director de Lightbridge Corporation (LTBR), informó varias adjudicaciones de acciones con fecha 08/28/2025. La presentación muestra cinco concesiones no derivadas separadas por un total de 20,000 acciones adquiridas en esa fecha, aumentando su propiedad beneficiaria a 34,055 acciones. El informe explica que la concesión de 5,000 acciones es una adjudicación de acciones restringidas (RSA) que vence en tres cuotas anuales iguales según la continuidad del servicio. Las demás concesiones son adjudicaciones de acciones restringidas basadas en desempeño (PSA) que vencen al cumplirse una condición de rendimiento especificada y pueden perderse si no están devengadas para el 12/31/2028. Magraw también posee opciones sobre acciones de empleado ejercitables por un total de 10,821 acciones a varios precios de ejercicio ($3.82, $10.80, $12.60, $55.20) y con vencimientos hasta el 12/02/2029. El formulario está firmado por un apoderado el 08/29/2025.

Daniel B. Magraw, Lightbridge Corporation(LTBR) 이사, 은(는) 08/28/2025자 여러 주식 부여를 신고했습니다. 제출 서류에는 해당 일자에 취득한 총 20,000주에 해당하는 다섯 건의 비파생 주식부여가 기록되어 있으며, 그의 실소유 지분은 34,055주로 증가했습니다. 서류에 따르면 5,000주 부여는 근속에 따라 3년간 매년 동일 비율로 베스팅되는 제한주(RSA)입니다. 나머지 부여는 성과 조건 충족 시 베스트되는 성과기반 제한주(PSA)로, 12/31/2028까지 베스팅되지 않으면 몰수될 수 있습니다. Magraw는 또한 여러 행사가($3.82, $10.80, $12.60, $55.20)와 만기일이 포함된 총 10,821주를 행사할 수 있는 종업원 스톡옵션을 보유하고 있으며, 만기일은 12/02/2029까지입니다. 서류는 08/29/2025에 대리인 서명으로 제출되었습니다.

Daniel B. Magraw, administrateur de Lightbridge Corporation (LTBR), a déclaré plusieurs attributions d'actions datées du 08/28/2025. Le dépôt indique cinq attributions non dérivées distinctes totalisant 20 000 actions acquises à cette date, portant sa détention bénéficiaire à 34 055 actions. Le document précise que l'attribution de 5 000 actions est une attribution d'actions restreintes (RSA) qui se libère en trois versements annuels égaux sous réserve de la poursuite du service. Les autres attributions sont des attributions d'actions restreintes liées à la performance (PSA) qui se libèrent à la réalisation d'une condition de performance spécifiée et peuvent être perdues si elles ne sont pas acquises avant le 12/31/2028. Magraw détient également des options d'achat d'actions de salarié exerçables pour un total de 10 821 actions à différents prix d'exercice ($3.82, $10.80, $12.60, $55.20) et échéances jusqu'au 12/02/2029. Le formulaire est signé par un mandataire le 08/29/2025.

Daniel B. Magraw, Direktor der Lightbridge Corporation (LTBR), meldete mehrere Aktienzuteilungen vom 08/28/2025. Die Einreichung weist fünf separate nicht-derivative Aktienzuteilungen aus, insgesamt 20.000 Aktien, die an diesem Datum erworben wurden und seinen wirtschaftlichen Besitz auf 34.055 Aktien erhöhen. In der Meldung wird erklärt, dass die Zuteilung von 5.000 Aktien eine Restricted Stock Award (RSA) ist, die in drei gleichen jährlichen Raten unter der Voraussetzung fortgesetzter Dienstzeit vestet. Die anderen Zuteilungen sind leistungsabhängige Restricted Stock Awards (PSA), die beim Erreichen einer festgelegten Leistungsbedingung vesten und verloren gehen können, falls sie bis zum 12/31/2028 nicht vested sind. Magraw hält außerdem Mitarbeiteraktienoptionen, die insgesamt 10.821 Aktien betreffen, mit verschiedenen Ausübungspreisen ($3.82, $10.80, $12.60, $55.20) und Laufzeiten bis zum 12/02/2029. Das Formular ist am 08/29/2025 von einem Bevollmächtigten unterzeichnet.

Positive
  • Director alignment with shareholders via time-based RSAs and performance-based PSAs that vest over multiple years
  • Structured incentives (performance conditions through 12/31/2028) that tie awards to future company performance
  • Options with varied strikes and expiries concentrate potential upside for continued service and long-term value creation
Negative
  • Potential dilution from 20,000 new shares and 10,821 option shares if fully vested/exercised
  • PSAs may be forfeited if performance is not achieved, indicating uncertainty in realizable compensation value

Insights

TL;DR: Routine compensation-related equity grants to a director; vesting and performance conditions reduce immediate dilution and risk.

The reported transactions are standard director compensation and incentive awards rather than open-market purchases or dispositions. The RSA vests pro rata over three years, while PSAs depend on achievement of specified performance metrics through the 2028 performance period, which limits immediate transferability and potential dilution. The existing stock options provide additional upside tied to share-price performance, with staggered strikes and expirations. For investors, this filing mainly signals executive alignment with long-term performance rather than a material change to capital structure.

TL;DR: Non-derivative grants total 20,000 shares; options cover 10,821 shares across four grants—impact appears modest given current holdings.

The Form 4 documents five grants on a single date, increasing beneficial ownership to 34,055 shares and adding time- and performance-based vesting constraints. The option positions (1,191; 4,371; 3,686; 1,573) are disclosed with strike prices and exercise/expiration dates, and one option is fully vested as noted. These are compensation mechanics rather than opportunistic insider trading; absent additional context on company float or outstanding shares, the filing is neutral from a market-impact perspective.

Daniel B. Magraw, direttore di Lightbridge Corporation (LTBR), ha segnalato più attribuzioni di azioni datate 08/28/2025. La comunicazione indica cinque distinti assegni non derivativi per un totale di 20.000 azioni acquisiste in quella data, portando la sua titolarità effettiva a 34.055 azioni. Il documento specifica che la concessione di 5.000 azioni è un premio in azioni vincolate (RSA) che matura in tre rate annuali uguali in base al servizio continuativo. Le altre assegnazioni sono premi in azioni vincolate legati a performance (PSA) che maturano al conseguimento di una condizione di performance stabilita e possono essere perse se non maturate entro il 12/31/2028. Magraw detiene inoltre opzioni azionarie da dipendente esercitabili per un totale di 10.821 azioni a diversi prezzi di esercizio ($3.82, $10.80, $12.60, $55.20) e con scadenze fino al 12/02/2029. Il modulo è firmato da un procuratore il 08/29/2025.

Daniel B. Magraw, director de Lightbridge Corporation (LTBR), informó varias adjudicaciones de acciones con fecha 08/28/2025. La presentación muestra cinco concesiones no derivadas separadas por un total de 20,000 acciones adquiridas en esa fecha, aumentando su propiedad beneficiaria a 34,055 acciones. El informe explica que la concesión de 5,000 acciones es una adjudicación de acciones restringidas (RSA) que vence en tres cuotas anuales iguales según la continuidad del servicio. Las demás concesiones son adjudicaciones de acciones restringidas basadas en desempeño (PSA) que vencen al cumplirse una condición de rendimiento especificada y pueden perderse si no están devengadas para el 12/31/2028. Magraw también posee opciones sobre acciones de empleado ejercitables por un total de 10,821 acciones a varios precios de ejercicio ($3.82, $10.80, $12.60, $55.20) y con vencimientos hasta el 12/02/2029. El formulario está firmado por un apoderado el 08/29/2025.

Daniel B. Magraw, Lightbridge Corporation(LTBR) 이사, 은(는) 08/28/2025자 여러 주식 부여를 신고했습니다. 제출 서류에는 해당 일자에 취득한 총 20,000주에 해당하는 다섯 건의 비파생 주식부여가 기록되어 있으며, 그의 실소유 지분은 34,055주로 증가했습니다. 서류에 따르면 5,000주 부여는 근속에 따라 3년간 매년 동일 비율로 베스팅되는 제한주(RSA)입니다. 나머지 부여는 성과 조건 충족 시 베스트되는 성과기반 제한주(PSA)로, 12/31/2028까지 베스팅되지 않으면 몰수될 수 있습니다. Magraw는 또한 여러 행사가($3.82, $10.80, $12.60, $55.20)와 만기일이 포함된 총 10,821주를 행사할 수 있는 종업원 스톡옵션을 보유하고 있으며, 만기일은 12/02/2029까지입니다. 서류는 08/29/2025에 대리인 서명으로 제출되었습니다.

Daniel B. Magraw, administrateur de Lightbridge Corporation (LTBR), a déclaré plusieurs attributions d'actions datées du 08/28/2025. Le dépôt indique cinq attributions non dérivées distinctes totalisant 20 000 actions acquises à cette date, portant sa détention bénéficiaire à 34 055 actions. Le document précise que l'attribution de 5 000 actions est une attribution d'actions restreintes (RSA) qui se libère en trois versements annuels égaux sous réserve de la poursuite du service. Les autres attributions sont des attributions d'actions restreintes liées à la performance (PSA) qui se libèrent à la réalisation d'une condition de performance spécifiée et peuvent être perdues si elles ne sont pas acquises avant le 12/31/2028. Magraw détient également des options d'achat d'actions de salarié exerçables pour un total de 10 821 actions à différents prix d'exercice ($3.82, $10.80, $12.60, $55.20) et échéances jusqu'au 12/02/2029. Le formulaire est signé par un mandataire le 08/29/2025.

Daniel B. Magraw, Direktor der Lightbridge Corporation (LTBR), meldete mehrere Aktienzuteilungen vom 08/28/2025. Die Einreichung weist fünf separate nicht-derivative Aktienzuteilungen aus, insgesamt 20.000 Aktien, die an diesem Datum erworben wurden und seinen wirtschaftlichen Besitz auf 34.055 Aktien erhöhen. In der Meldung wird erklärt, dass die Zuteilung von 5.000 Aktien eine Restricted Stock Award (RSA) ist, die in drei gleichen jährlichen Raten unter der Voraussetzung fortgesetzter Dienstzeit vestet. Die anderen Zuteilungen sind leistungsabhängige Restricted Stock Awards (PSA), die beim Erreichen einer festgelegten Leistungsbedingung vesten und verloren gehen können, falls sie bis zum 12/31/2028 nicht vested sind. Magraw hält außerdem Mitarbeiteraktienoptionen, die insgesamt 10.821 Aktien betreffen, mit verschiedenen Ausübungspreisen ($3.82, $10.80, $12.60, $55.20) und Laufzeiten bis zum 12/02/2029. Das Formular ist am 08/29/2025 von einem Bevollmächtigten unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
MAGRAW DANIEL B

(Last) (First) (Middle)
C/O LIGHTBRIDGE CORPORATION
11710 PLAZA AMERICA DRIVE, SUITE 2000

(Street)
RESTON VA 20190

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
LIGHTBRIDGE Corp [ LTBR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/28/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/28/2025 A(1) 5,000 A $0 19,055 D
Common Stock 08/28/2025 A(2) 5,000 A $0 24,055 D
Common Stock 08/28/2025 A(2) 5,000 A $0 29,055 D
Common Stock 08/28/2025 A(2) 3,000 A $0 32,055 D
Common Stock 08/28/2025 A(2) 2,000 A $0 34,055 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy) $3.82 (3) 12/02/2029 Common Stock 1,191 1,191 D
Employee Stock Option (right to buy) $10.8 (3) 08/06/2028 Common Stock 4,371 4,371 D
Employee Stock Option (right to buy) $12.6 (3) 10/26/2027 Common Stock 3,686 3,686 D
Employee Stock Option (right to buy) $55.2 (3) 11/20/2025 Common Stock 1,573 1,573 D
Explanation of Responses:
1. Represents a grant of restricted stock awards (RSAs). These RSAs vest in three equal installments on the first, second and third anniversaries of the date of grant, contingent on the reporting person's continued service on each such vesting date.
2. Represents a grant of performance-based restricted stock awards (PSAs). These PSAs vest subject to achievement of a specified performance condition, and at the time of certification thereof, contingent on the reporting person's continued service on the certification date. PSAs that remain unvested as of December 31, 2028 (the end of the performance period) will automatically be forfeited and cancelled without consideration.
3. This option is fully vested as of the date of this report.
/s/ Larry Goldman, Attorney-in-Fact for Daniel B. Magraw 08/29/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed the Form 4 for LTBR and what is their relationship to the company?

The Form 4 was filed on behalf of Daniel B. Magraw, who is listed as a Director of Lightbridge Corporation.

What transactions were reported on 08/28/2025 for LTBR?

The reporting person acquired five non-derivative grants totaling 20,000 shares on 08/28/2025, increasing beneficial ownership to 34,055 shares.

What are the vesting conditions for the restricted stock awards and performance awards?

The RSAs vest in three equal annual installments contingent on continued service; the PSAs vest only upon achieving specified performance conditions and lapse if unvested by 12/31/2028.

What employee stock options does Magraw hold according to the filing?

He holds options exercisable for 1,191, 4,371, 3,686, and 1,573 shares (total 10,821), with strike prices of $3.82, $10.80, $12.60, and $55.20, expiring between 11/20/2025 and 12/02/2029.

When was the Form 4 signed and by whom?

The form is signed by Larry Goldman, Attorney-in-Fact for Daniel B. Magraw on 08/29/2025.
Lightbridge Corp

NASDAQ:LTBR

LTBR Rankings

LTBR Latest News

LTBR Latest SEC Filings

LTBR Stock Data

392.09M
23.64M
8.79%
34.23%
19.28%
Electrical Equipment & Parts
Services-management Consulting Services
Link
United States
RESTON